(Q43065846)

13 November 2017

Co-prescription of H2 receptor blockers and proton pump inhibitors with warfarin in general practice (English)

1 reference

13 November 2017

1 reference

1

1 reference

13 November 2017

Rubin GP

2

1 reference

PMCID

1741442

13 November 2017

O'Flanagan H

series ordinal

3

1 reference

PMCID

1741442

13 November 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

Postgraduate Medical Journal

13 November 2017

1 reference

13 November 2017

75

1 reference

13 November 2017

890

1 reference

13 November 2017

721-722

1 reference

Safety of proton pump inhibitors--an overview

13 November 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1741442

A study of the interaction of omeprazole and warfarin in anticoagulated patients

25 May 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1741442

The use of long-term acid-suppression therapy

25 May 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10567597

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Stereoselective interaction of omeprazole with warfarin in healthy men

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10567597

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/PGMJ.75.890.721

1 reference

13 November 2017

1 reference

13 November 2017

1 reference

PMCID

1741442